Skip to main content
Log in

Prävention venöser Thromboembolien

Direktes orales Antikoagulanz bewährt sich bei ambulanten Tumorpatienten

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Konstandinides SV, Torbicki A, Agnelli G et al. Eur Heart J 2014;35:3033–80

    Article  Google Scholar 

  2. Khorana AA, Soff GA Kakkar AK et al. N Engl J Med 2019; 380: 720–8

    Article  CAS  Google Scholar 

  3. Young AM, Marshall A, Thirlwall J et al. J Clin Oncol 2018; 36: 2017–23

    Article  CAS  Google Scholar 

  4. Raskob GE, van ES N, Verhamme P et al. N Engl J Med 2018; 378: 615–24

    Article  CAS  Google Scholar 

  5. Agnelli G. N Engl J Med 2019; 380: 781–3

    Article  Google Scholar 

  6. Khorana AA, Noble S, Lee AYY et al. J Thromb Haemost 2018;16:1891–4

    Article  CAS  Google Scholar 

Originalie

  • Carrier M, Abou-Nassar K, Mallick R et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711–9

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dirk Skowasch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Skowasch, D. Direktes orales Antikoagulanz bewährt sich bei ambulanten Tumorpatienten. Pneumo News 11, 22–23 (2019). https://doi.org/10.1007/s15033-019-1194-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-019-1194-x

Navigation